KRAS靶點(diǎn)難成藥?-整體解決方案來幫您
KRAS熱度已經(jīng)消退了?NO...據(jù)調(diào)查,現(xiàn)在除傳統(tǒng)針對(duì)KRAS靶點(diǎn)小分子藥物外,更多玩家嘗試新興療法征服這一“不可成藥"的難題,如疫苗,TCR-T療法等。KRAS可以被細(xì)胞外信號(hào)以及來自細(xì)胞器等亞細(xì)胞結(jié)構(gòu)的信號(hào)所激活。在正常的生理環(huán)境下,野生型KRAS主要處于不活躍的GDP結(jié)合狀態(tài)。信號(hào)促使KRAS脫離GDP,并與GTP結(jié)合,將KRAS轉(zhuǎn)化為激活狀態(tài)。激活的KRAS能夠結(jié)合并激活效應(yīng)蛋白,如RAF激酶、PI3K和RalGDS,促進(jìn)下游級(jí)聯(lián)的信號(hào)通路,如MAPK、PI3K和Ral-GEFs通路。這些信號(hào)通路通過細(xì)胞復(fù)制、生長(zhǎng)、分化和促進(jìn)細(xì)胞周期進(jìn)程。一個(gè)激活的致癌KRAS基因?qū)е乱粋€(gè)突變的KRAS蛋白,由于GTP水解率大大降低,異常長(zhǎng)時(shí)間保持其活性GTP結(jié)合狀態(tài)。當(dāng)KRAS蛋白被困在“ON"位置時(shí),下游效應(yīng)通路也保持活躍,細(xì)胞增殖率保持很高。其他仍然活躍的效應(yīng)通路包括那些促進(jìn)腫瘤發(fā)展過程的通路,如有絲分裂、細(xì)胞遷移、腫瘤侵襲和血管生成。 一、高通量篩選試劑盒HTRF®技術(shù)提供均相,免洗KRAS結(jié)合檢測(cè)試劑盒,通過這些已驗(yàn)證的試劑盒,可直接用于抑制劑篩選,無需優(yōu)化,每個(gè)試劑盒配有重組蛋白、檢測(cè)試劑和緩沖液。如下圖所示,使用抗Tag1-SOS1(供體)和抗Tag2-XL665(受體)檢測(cè)Tag1-SOS1與Tag2-KRAS-G12C之間的相互作用。當(dāng)供體和受體抗體由于SOS1和KRAS-G12C結(jié)合而接近時(shí),供體抗體的激發(fā)觸發(fā)向受體抗體的熒光共振能量轉(zhuǎn)移(FRET),受體抗體在665nm處特異性發(fā)射。這種特異性信號(hào)與KRAS-G12C/SOS1相互作用的程度成正比。因此,化合物或抗體阻斷KRAS-G12C/SOS1的相互作用會(huì)導(dǎo)致HTRF®信號(hào)的減少。
使用已知抑制劑對(duì)試劑盒進(jìn)行驗(yàn)證,均獲得相應(yīng)較好的IC50并且與已報(bào)道文獻(xiàn)結(jié)果相一致。
相關(guān)推薦:
貨號(hào) | 產(chǎn)品名稱 | 規(guī)格 |
63ADK000CB15PEG | KRAS-WT/SOS1 binding assay kit | 500 tests |
63ADK000CB19PEG | KRAS-WT/RAF1 binding assay kit | 500 tests |
63ADK000CB47PEG | KRAS-G12D/RAF1 binding assay kit | 500 tests |
63ADK000CB17PEG | KRAS-G12D/SOS1 binding assay kit | 500 tests |
63ADK000CB20PEG | KRAS-G12C/RAF1 binding assay kit | 500 tests |
63ADK000CB16PEG | KRAS-G12C/SOS1 binding assay kit | 500 tests |
63ADK000CB22PEG | KRAS-G12V/RAF1 binding assay kit | 500 tests |
63ADK000CB28PEG | KRAS G12V GTP binding kit | 500 tests |
二、KRAS靶點(diǎn)相關(guān)蛋白全部KRAS相關(guān)蛋白均已原核表達(dá)系統(tǒng)(E.coli)進(jìn)行表達(dá)。通過HTRF方式驗(yàn)證其結(jié)合活性。 1、KRAS WTThe KRAS-WT activity was assayed with HTRF technology. The reaction was performed by incubating the KRAS- WT protein, GTP, cRAF and beads at 25℃ for 60 min, then reading Ratio 665/620nm signal.
2.KRAS-G12CThe KRAS-G12C activity was assayed with HTRF technology. The reaction was performed by incubating the KRAS-G12C protein, GTP, cRAF and beads at 25℃ for 60 min, then reading Ratio 665/620nm signal. 3.KRAS-G12D The KRAS-G12D activity was assayed with HTRF technology. The reaction was performed by incubating the KRAS-G12D protein, GTP, cRAF and beads at 25℃ for 60 min, then reading Ratio 665/620nm signal
4.KRAS-G12RThe KRAS-G12R activity was assayed with HTRF technology. The reaction was performed by incubating the KRAS-G12R protein, GTP, cRAF and beads at 25℃ for 60 min, then reading Ratio 665/620nm signal.
5.KRAS-G12VThe KRAS- G12V activity was assayed with HTRF technology. The reaction was performed by incubating the KRAS- G12V protein, GTP, cRAF and beads at 25℃ for 60 min, then reading Ratio 665/620nm signal.
6.KRAS-G13CThe KRAS-G13C activity was assayed with HTRF technology. The reaction was performed by incubating the KRAS-G13C protein, GTP, cRAF and beads at 25℃ for 60 min, then reading Ratio 665/620nm signal.
7.KRAS Q61HThe KRAS-Q61H activity was assayed with HTRF technology. The reaction was performed by incubating the KRAS-Q61H protein, GTP, cRAF and beads at 25℃ for 60 min, then reading Ratio 665/620nm signal.
8.SOS1
9.RAF
相關(guān)推薦:
貨號(hào) | 品名 | 規(guī)格 |
UA080001 | KRAS | 100μg |
UA080002 | Kras[G12C] | 100μg |
UA080003 | Kras[G12V] | 100μg |
UA080004 | Kras[G12D] | 100μg |
UA080005 | Kras[G12R] | 100μg |
UA080006 | Kras[G13C] | 100μg |
UA080007 | Kras[G13D] | 100μg |
UA080008 | Kras[Q61H] | 100μg |
UA080014 | cRAF | 50μg |
UA080015 | cRAF | 50μg |
UA080016 | SOS1 | 100μg |
*以上KRAS蛋白無GTP bound,如需GTP bound,可聯(lián)系優(yōu)寧維。上述蛋白,常規(guī)規(guī)格有:50μg,100μg和1mg,如需更大規(guī)格,可聯(lián)系優(yōu)寧維定制。 三、Anti-Tag抗體話說,不想用試劑盒的情況下,如何建立assay呢?蛋白已經(jīng)有了,還差檢測(cè)抗體...這不就來了!Anti-Tag的HTRF熒光抗體,在實(shí)現(xiàn)高通量,操作簡(jiǎn)便等其他技術(shù)優(yōu)勢(shì)的同時(shí),可以為assay的建立提供最大的靈活性。無關(guān)乎蛋白本身,僅針對(duì)標(biāo)簽如His,GST,F(xiàn)LAG等,選擇對(duì)應(yīng)的配對(duì)抗體即可實(shí)現(xiàn)實(shí)驗(yàn)方法學(xué)開發(fā)。比如:參考上述蛋白KRAS G12C(his Tag)和SOS1(GST tag),選擇抗體配對(duì)有幾種方式可供參考:
KRAS donor | SOS1 accpetor |
Anti his Eu | Anti GST XL665 |
Anti GST D2 | |
Anti His Tb | Anti GST XL665 |
Anti GST D2 | |
KRAS accpetor | SOS1 donor |
Anti his XL665 | Anti GST Eu |
Anti his D2 | |
Anti his XL665 | Anti GST Tb |
Anti his D2 | |
PPI - Europium detection buffer | |
PPI - Terbium detection buffer |
下圖為Anti-GST-Tb SOS1與Anti-his-XL665 KRAS G12C搭配組合展示。
相關(guān)推薦:
Anti-tag antibodies | ||
貨號(hào) | 品名 | 規(guī)格 |
61HISDLF | MAb Anti 6HIS-d2 | 1000 tests |
61HISKLA | MAb Anti 6HIS-Eu cryptate | 5000 tests |
61HI2KLA | MAb Anti 6HIS-Eu cryptate Gold | 5000 tests |
61HISTLF | MAb Anti 6HIS-Tb cryptate | 1000 tests |
61HI2TLF | MAb Anti 6HIS-Tb cryptate Gold | 1000 tests |
61HISXLF | MAb Anti 6HIS-XL665 | 1000 tests |
61MYCDAF | MAb Anti cmyc-d2 | 1000 tests |
61MYCKLA | MAb Anti cmyc-Eu cryptate | 5000 tests |
61MYCTAF | MAb Anti cmyc-Tb cryptate | 1000 tests |
61MYCXLF | MAb Anti cmyc-XL665 | 1000 tests |
61DNPKLA | MAb Anti DNP-Eu cryptate | 5000 tests |
61DNPXLA | MAb Anti DNP-XL665 | 5000 tests |
61FG2DLF | MAb Anti FLAG M2-d2 | 1000 tests |
61FG2KLA | MAb Anti FLAG M2-Eu cryptate | 5000 tests |
61FG2TLF | MAb Anti FLAG M2-Tb cryptate | 1000 tests |
61FG2XLF | MAb Anti FLAG M2-XL665 | 1000 tests |
61GSTDLF | MAb Anti GST-d2 | 1000 tests |
61GSTKLA | MAb Anti GST-Eu cryptate | 5000 tests |
61GSTTLF | MAb Anti GST-Tb cryptate | 1000 tests |
61GSTXLF | MAb Anti GST-XL665 | 1000 tests |
610HADAF | MAb Anti HA-d2 | 1000 tests |
610HAKLA | MAb Anti HA-Eu cryptate | 5000 tests |
610HATAF | MAb Anti HA-Tb cryptate | 1000 tests |
610HAXLF | MAb Anti HA-XL665 | 1000 tests |
61MBPDAA | MAb Anti MBP-d2 | 5000 tests |
61MBPKAA | MAb Anti MBP-Eu cryptate | 5000 tests |
61MBPTAA | MAb Anti MBP-Tb cryptate | 5000 tests |
Buffers | ||
貨號(hào) | 品名 | 規(guī)格 |
61DB9RDF | PPI - Europium detection buffer | 200ml |
61DB10RDF | PPI - Terbium detection buffer | 200ml |
三、下游磷酸化蛋白檢測(cè)Alpha®和HTRF®技術(shù)基于細(xì)胞水平進(jìn)行下游KRAS信號(hào)通路的研究,包括MAPK、PI3K和Ral-GEFs通路。這些細(xì)胞信號(hào)分析能夠區(qū)分化合物調(diào)節(jié)下游KRAS通路的功效。HTRF®仍然利用夾心法原理,標(biāo)記的特異性抗體識(shí)別磷酸化蛋白和總蛋白從而進(jìn)行定量檢測(cè)。全過程無需洗滌,特異性好,靈敏度高。
下圖為p-ERK(圖左)和p-NFkB(圖右)磷酸化試劑盒靈敏度與WB對(duì)比,靈敏度高出30倍不等。
與HTRF®技術(shù)不同,Alpha®雖然也是均相檢測(cè)檢測(cè)技術(shù),但其基于化學(xué)發(fā)光原理,利用兩個(gè)微珠進(jìn)行檢測(cè)來實(shí)現(xiàn)更低的實(shí)驗(yàn)背景和超高靈敏度。一個(gè)抗體被生物素化并與鏈霉親和素包被的供體微珠結(jié)合,受體微珠則直接與另一個(gè)抗體結(jié)合。抗體與磷酸化蛋白(總蛋白)結(jié)合使供體和受體微珠靠近。供體微珠的激發(fā)使得單線態(tài)氧擴(kuò)散至受體微珠,從而發(fā)射615nm波長(zhǎng)的光信號(hào)。Alpha®的檢測(cè)信號(hào)與樣本中存在的磷酸化蛋白(總蛋白)的數(shù)量成正比。Alpha®原理如下圖。
相關(guān)推薦:
貨號(hào) | 產(chǎn)品名稱 | 規(guī)格 |
64NFBPEG | NFkB phospho-S536 kit | 500tests |
64NFTPEG | NFkB total kit | 500tests |
64AERPEG | Advanced phospho-ERK (Thr202/Tyr204)cellular kit | 500tests |
64NRKPEG | Total ERK cellular kit | 500tests |
64ME1PEG | Phospho-MEK1 (Ser218/222) cellular kit | 500tests |
64NE1PEG | Total MEK1 cellular kit | 500tests |
64AKTPEG | Phospho-AKT1/2/3 (Thr308) cellular kit | 500tests |
64AKSPEG | Phospho-AKT1/2/3 (Ser473) cellular kit | 500tests |
64NKTPEG | Total AKT cellular kit | 500tests |
64AKTPEG | HTRF PHOSPHO-AKT (THR308) DETECTION KITS | 500tests |
64TORPEG | Phospho-mTOR (Ser2448) cellular kit | 500tests |
ALSU-PAKT-B500 | AlphaLISA SureFire Ultra AKT 1/2/3 (pS473) Assay Kit | 500assays |
ALSU-TAKT-B500 | Total AKT1/2/3 AlphaLISA SureFire Ultra Detection Kit | 500assays |
ALSU-PMTOR-C500 | AlphaLISA phospho-mTOR (Ser2448) Assay Kit | 500assays |
ALSU-TMTOR-B500 | AlphaLISA total mTOR Assay Kit | 500assays |
四、3D細(xì)胞增殖
基于ATP的發(fā)光法測(cè)定細(xì)胞增殖和細(xì)胞毒性的分析原理。用適當(dāng)緩沖液直接裂解細(xì)胞后,對(duì)細(xì)胞ATP進(jìn)行定量。在裂解細(xì)胞釋放的ATP作用下,ATP與添加的熒光素反應(yīng)產(chǎn)生光。
ATPlite 3D and ATPlite 1step 3D Assay 操作流程如下:
ATPlite 3D檢測(cè)可以允許細(xì)胞密度較高情況下進(jìn)行檢測(cè),并且比2D檢測(cè)效果明顯。
相關(guān)推薦:
貨號(hào) | 產(chǎn)品名稱 | 規(guī)格 |
6066736 | ATPlite 1step 3D | 10ml/100tests |
6066943 | ATPlite 3D | 300tests |
6016736 | ATPlite 1step Luminescence Assay System | 10ml |
6016731 | 100ml | |
6016739 | 1000ml | |
6016943 | 300 Assay | |
6016941 | ATPlite Luminescence Assay System | 1000 Assay |
6016947 | 5000 Assay | |
6016949 | 10000 Assay |
四、微孔板耗材1.3D細(xì)胞培養(yǎng)板①板底為高度生物相容的,超低吸附力聚合物包被du有的合成聚合物MPC,源于細(xì)胞膜組分,與極性基團(tuán)的磷脂(磷脂酰膽堿)具有相同的結(jié)構(gòu),提供自然生長(zhǎng)環(huán)境,并消除批間差異。②易形成形態(tài)大小均勻的球體細(xì)胞球體高質(zhì)量形成率,細(xì)胞形態(tài)均已一致,板材的均勻性高,可隨時(shí)聚焦進(jìn)行圖片拍攝,提供重復(fù)性更高的數(shù)據(jù)及更高效更高質(zhì)量的成像。③無需更換培養(yǎng)基實(shí)驗(yàn)的佳選擇圓底板,性價(jià)比高。
相關(guān)推薦:
貨號(hào) | 產(chǎn)品名稱 | 規(guī)格 |
6055330 | CellCarrier Spheroid ULA Microplates | Case of 10 |
6055334 | Case of 40 |
2. 其他相關(guān)培養(yǎng)板,檢測(cè)板
底透微孔板(View Plate) | |||||||
實(shí)驗(yàn)應(yīng)用 | 顏色 | 特點(diǎn) | 孔數(shù)目 | Case of 40 | Case of 50 | Case of 60 | Case of 160 |
化學(xué)發(fā)光實(shí)驗(yàn) | 白色 | 底透,TC處理 | 96孔 | 6005181 | |||
384孔 | 6007480 | ||||||
黑色 | 底透,TC處理 | 96孔 | 6005182 | ||||
384孔 | 6007460 | ||||||
標(biāo)準(zhǔn)微孔板(OptiPlate) | |||||||
實(shí)驗(yàn)應(yīng)用 | 顏色 | 特點(diǎn) | 孔數(shù)目 | Case of 40 | Case of 50 | Case of 60 | Case of 160 |
化學(xué)發(fā)光實(shí)驗(yàn)熒光實(shí)驗(yàn) | 白色 | 非底透 | 96孔 | 6005290 | |||
384孔 | 6007290 | ||||||
黑色 | 非底透,TC處理 | 96孔 | 6005270 | ||||
384孔 | 6007270 | ||||||
細(xì)胞培養(yǎng)板(CulturPlate) | |||||||
實(shí)驗(yàn)應(yīng)用 | 顏色 | 特點(diǎn) | 孔數(shù)目 | Case of 50 | Case of 160 | Case of 200 | |
細(xì)胞培養(yǎng) | 白色 | 非底透,TC處理 | 24孔 | 6005168 | |||
96孔 | 6005680 | 6005688 | 6005689 | ||||
384孔 | 6007680 | 6007688 | 6007689 | ||||
黑色 | 非底透,TC處理 | 96孔 | 6005660 | 6005668 | 6005669 | ||
384孔 | 6007660 | 6007668 | |||||
HTRF*Alpha檢測(cè)微孔板 | |||||||
應(yīng)用領(lǐng)域 | 顏色 | 特點(diǎn) | 孔數(shù)目 | Case of 25 | Case of 50 | Case of 200 | |
HTRF實(shí)驗(yàn) | 白色 | 非底透,潛孔 | 96孔 | 66PL96025 | 6005359 | ||
Alpha實(shí)驗(yàn) | 384孔 | 6008280 | 6008289 |
更多實(shí)驗(yàn)相關(guān)微孔板,請(qǐng)聯(lián)系優(yōu)寧維。
上海優(yōu)寧維生物科技股份有限公司
試劑 | 耗材 | 儀器 | 軟件 | 定制 | 實(shí)驗(yàn)服務(wù) | 供應(yīng)鏈
微信公眾平臺(tái):優(yōu)寧維抗體專家,歡迎關(guān)注!
小優(yōu)博士(小程序):5大課堂, 讓你的科研不再難!